JAMIE KAUSCH: Open Payments
NPI 1487395695 · PENNINGTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$734 in 22 payments from 7 companies in 2025. Trend: 2023 $444 · 2024 $2,279 · 2025 $734
Food & beverage: $734
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 5 | $332 |
| Sumitomo Pharma America, Inc. | 10 | $225 |
| Medtronic, Inc. | 3 | $103 |
| Hologic Sales and Service, LLC | 1 | $23 |
| MILLICENT US INC | 1 | $19 |
| Astellas Pharma US Inc | 1 | $18 |
| ABBVIE INC. | 1 | $14 |
Products named: GEMTESA, Axonics, Bulkamid, INTERSTIM, AMS 800 Artificial Urinary Sphincter, APTIMA, INTRAROSA, Veozah.
Industry payments across NJ — which companies pay providers there.
